Apollo Ventures is a venture capital firm in Germany that focuses on assets that treat, prevent, or even reverse age-related diseases such as alzheimer's, heart disease, sarcopenia, frailty, and cancer, with the goal of increasing healthy human lifespan. Founded 2016 in Hamburg, Germany by James Peyer, Nils Regge and Ole Mensching, and this venture capital firm invests in early stage ventures and seed. Its portfolio companies include Aeovian Pharmaceuticals, Samsara Therapeutics and Cleara Biotech. As of February 2020, Apollo Ventures has made four investments. Their most recent investment was on October 3, 2019, when Aeovian Pharmaceuticals raised $37M.
Timeline
People
Dr. Steven Leunert
CFO
Dr. Victor Pavlenko
Venture Developer
James Peyer
Co-founder
James Peyer, PhD
Founder
Jens Eckstein, PhD
Managing Partner
Nils Regge
Co-Founder & Managing Director
Ole Mensching, PhD
Co-Founder & Head of HR
Victor Bustos, PhD
Venture Analyst
Further reading
This Scientist-Turned-VC Wants to Extend Life - NEO.LIFE - Medium
Karen Weintraub
Web
Documentaries, videos and podcasts
Companies
Aeovian Pharmaceuticals
Cleara Biotech
Samsara Therapeutics
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 2
Carla Faraguna
Golden People and Operations. - 3
Henry Ogolla
Passionate about reading and writing. - 4
Aime Anne Nisay
QA Engineer of web and mobile applications - 5
Julius John Villarisco
Every day is a new learning for me, new opportunity every time. Never limit my self, think outside the box. - 6
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur